Boombostic Health

Welcome to Boombostic Health, where we challenge the business of healthcare and explore bold ideas that drive meaningful change. Each week we bring you candid conversations with top experts, innovators and leaders exploring the latest trends and technologies shaping the future of healthcare.

Ep 56: How At-Home Lab Testing Works (Behind the Kit) 12/23/2025

Ep 55: Stigma is a barrier. At-home testing breaks it. HIV + STI Testing. 12/16/2025

Ep 55: Stigma is a barrier. At-home testing breaks it. HIV + STI Testing. Show Notes Healthcare keeps talking about AI, affordability, and outcomes… But most systems are still ignoring the front door that drives care decisions: diagnostics. Recorded In the Wild at HLTH 2025 in Las Vegas, Bradley Bostic sits down with James York (Chief Commercial Officer + Head of Government Affairs, Molecular Testing Labs) to unpack a hard truth: If you can’t make testing accessible, convenient, and trackable… you can’t build reliable care pathways. In this episode, James breaks down why diagnostics is a flywheel—the top-of-funnel that activates patients—and why “we have Quest/Labcorp, so we’re good” is the exact mindset keeping innovation stuck. He also shares how Molecular Testing Labs attacked the hardest access problem first (HIV/STI), what happened when they removed friction from PrEP care, and why lab-based at-home testing matters because it protects the integrity of the data (not just the experience). You’ll also hear a forward-looking take on self-collection, routine testing for chronic disease + wellness, cost transparency, and where AI could take us next—toward forecasting health like we forecast weather. What you’ll learn: Why James calls diagnostics “the flywheel” for activating patients The two stats that should change how leaders budget for labs (“70% of clinical decisions” vs “7% of spend” — as James cites) Why self-collected, lab-processed testing beats “rapid-only” testing when data/reporting matters How at-home testing can reduce stigma and improve public-health surveillance What “patient-as-decision-maker” healthcare could look like in the next 5–10 years If you care about prevention, care gaps, data integrity, and making healthcare actually work for more people—this one’s for you. Chapters 00:00 — Boombostic Health “In the Wild” @ HLTH 2025 (Vegas) 00:45 — Baseball dads, real life, and the cost of ambition 02:05 — “Everyone should have access to diagnostics” (mission) 03:00 — Why the “Diagnostic Zone” is a signal moment 04:30 — The stat gap: labs drive decisions, not spending 05:45 — Why they started with HIV/STI (the hardest use case) 07:30 — Self-collection scale + what it unlocked for access 08:10 — PrEP friction: stigma + testing barriers (and the unlock) 09:45 — The Abbott at-home multiplex test: what’s new + why it matters 11:05 — Rapid vs lab: the real issue is data integrity + reporting 12:40 — What’s next: routine tests, chronic disease, wellness expansion 16:15 — AI, avatars, and “forecasting health like weather” 18:10 — Bradley’s lens: signals, patterns, and getting patients on the right interventions 20:34 — Wrap + why data in will determine everything #BoombosticHealth #HLTH2025 #Diagnostics #MolecularDiagnostics #LabTesting #PreventiveCare #AtHomeTesting #PublicHealth #CareGaps #HealthcareInnovation #DigitalHealth #AIinHealthcare #PrEP #STITesting /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/39428350

Ep 54: The Business of Making Healthcare Data Trustworthy 12/09/2025

Ep 54: The Business of Making Healthcare Data Trustworthy Summary Healthcare is racing to be “AI ready.” But most of the industry is still trying to turn billing exhaust into strategy. In this episode, Bradley Bostic sits down with Ryan Leurck, Co-Founder & Chief Analytics Officer at Kythera Labs, to cut through the noise and get blunt about what actually makes AI work in healthcare. Because the truth is simple—and uncomfortable: If your data can’t be trusted by humans, it can’t be trusted by AI. And in healthcare, much of our data was never designed for the questions we’re now demanding it answer. Takeaways Why claims, EHR, and lab data weren’t built for strategy—and how that limits AI. The risk of modern AI: “AI is not always right, but it always sounds sure.” Why healthcare data is still optimized for coding and billing, not predictive insight. Kythera’s mission to “reduce the uncertainty in the use of healthcare data.” How leaders should think about “AI ready” without falling for hype. The reality of claims: a “big bag of receipts” that can mislead without expert context. Why data quality and missingness matter as much as the data you do have. A practical vision for AI inside provider orgs: agents that function like analysts/interns, not decision-makers. Chapters 00:00 Introduction to AI in Healthcare 01:23 Ryan Leurck's Journey from Aerospace to Healthcare 03:22 The Current AI Landscape and Its Misconceptions 06:54 Kythera Labs: Reducing Uncertainty in Healthcare Data 11:13 Challenges of Healthcare Data and AI Integration 18:03 Opportunities for AI in Healthcare 22:52 Kythera's Target Audience and Solutions 27:41 The Role of AI in Operational Efficiency 31:18 Data Privacy and Accessibility in Healthcare 34:30 The Future of AI in Healthcare Keywords AI, healthcare, data analytics, machine learning, healthcare technology, Kythera Labs, artificial intelligence, data quality, healthcare providers, operational efficiency /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/39345655

Ep 53: Screening for Dementia with AI - Your Brain’s Early Warning System 12/02/2025

Ep 53: Screening for Dementia with AI - Your Brain’s Early Warning System Summary By the time most people hear “dementia,” their brain has been sounding the alarm for years. In this episode of Boombostic Health, Dr. John Showalter shares his journey from internist to healthcare technology innovator. He explains how AI and digital tools can support early detection and intervention for cognitive decline—before daily life starts to fall apart. The conversation highlights how lifestyle changes can improve cognitive health, why screening the brain should be as routine as checking blood pressure, and how integrating technology into healthcare systems can scale better outcomes. Real-life success stories show what’s possible when you catch problems early and give people a path to act. Takeaways Dr. Showalter’s journey from medicine to healthcare technology is inspiring. AI can enhance caregiver efficiency and patient care. Early detection of cognitive decline is crucial for effective intervention. Lifestyle changes can significantly impact cognitive health. Integration of technology into healthcare systems is essential for scalability. Personalized brain health action plans can improve patient outcomes. Social isolation and loss of purpose are key factors in cognitive decline. Real-life success stories demonstrate the effectiveness of early intervention. Healthcare innovation requires collaboration between technology and clinical expertise. The future of cognitive health lies in proactive, lifestyle-based approaches. Chapters 00:00 Innovating Healthcare: A Journey into Technology 02:39 The Role of AI in Patient Care 05:34 Cognitive Health: Early Detection and Intervention 08:24 Lifestyle Changes and Cognitive Decline 11:07 Integrating Technology into Healthcare Systems 14:08 The Future of Cognitive Health and AI 17:03 Real-Life Success Stories in Cognitive Health About Dr. Showalter Dr. John Showalter is an internist and clinical informatics leader who has been obsessed with the data side of care since his first DNA research job at 14. Trained in biomedical engineering and medical informatics, he went on to lead major EHR implementations and build a state-of-the-art analytics center from a $0 to $6.5M budget, earning a Premier 100 IT Leaders award along the way. Today, he focuses on turning complex data and AI into practical tools clinicians actually use, helping detect disease earlier and improve patient outcomes at scale. Resources Linus Health – digital cognitive assessment and brain health platform: https://www.linkedin.com/company/linus-health/posts/?feedView=all Connect with Dr. John Showalter on LinkedIn: https://www.linkedin.com/in/johnshowaltermd/ Boombostic Health podcast – more episodes on AI, diagnostics, and the future of care: https://www.boombostichealth.com/podcast Tags healthcare innovation, artificial intelligence, cognitive health, early detection, lifestyle changes, patient care, technology integration, healthcare systems, dementia, health tech /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/39239660

Ep 52: Mental Health, Cancer, and the Gut Data We’re Not Using 11/25/2025

Ep 52: Mental Health, Cancer, and the Gut Data We’re Not Using We talk a lot about “data-driven healthcare,” yet we’re still blind to one of the most important data layers: the microbiome. Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don’t account for it. In this episode of Boombostic Health, I sit down with Paul Denslow, CEO & co-founder of Intus Bio, to dig into how GutID turns the microbiome into hard infrastructure: high-resolution gut data, a score you can track, and a way to see whether your interventions are actually moving risk—not just spend. In this episode, we cover: Why microbiome disruption often precedes mental health issues and cancer How GutID converts millions of bacterial data points into a single, trackable gut score Why behavioral health and functional practitioners have been early adopters The problem with “just take a probiotic” in the absence of baseline gut data How AI + high-resolution microbiome testing open a real prevention window What a serious prevention and longevity strategy looks like when gut data is included If you’re responsible for care delivery, benefits strategy, or long-term risk, ignoring this data layer is no longer a neutral decision. Watch the full conversation to see why mental health, cancer, and your “bacterial you” belong at the center of modern prevention. About our guest: Paul Denslow is the CEO and co-founder of Intus Bio, the company behind GutID. With a background in finance and big data, Paul partnered with co-founder Mark Driscoll, a pioneer in next-generation sequencing, to build a platform that treats the microbiome as a hard data problem—not a mystery. Intus Bio’s GutID test and Titan 1 platform are used by clinicians and practitioners to generate high-resolution microbiome data that can be translated into actionable prevention and disease insights. Links & Resources: Learn more about GutID: Learn more about Intus Bio: Watch more Boombostic Health episodes: https://www.boombostichealth.com/podcast /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/39168780

Ep 51: AI Can’t Fix Virtual Care’s 70% Lab Problem 11/18/2025

Ep 51: AI Can’t Fix Virtual Care’s 70% Lab Problem Virtual care is scaling. AI is everywhere. But when lab completion falls from ~70% in-clinic to ~30% in virtual care, the whole model breaks. Virtual Care Without Labs Is Just Zoom - Even with AI. In this Boombostic Health in the Wild episode from HLTH 2025, Bradley Bostic sits down with Maitham Dib, founder of Junction, to unpack the "real" bottleneck: turning lab orders into lab results. They dig into how Junction: * White-labels lab infrastructure so any virtual or hybrid care model can deploy labs across all 50 states * Uses data from ~3.4 million lab tests annually to model what actually drives lab completion * Dynamically routes patients across PSC visits, at-home kits, and at-home phlebotomy - based on real-world behavior * Plugs into telehealth and AI agents that still need working diagnostic rails to be useful Chapters 00:00 – Lab in the basement, but core to care 02:00 – 70% in-clinic vs. ~30% virtual: the lab completion cliff 03:30 – Junction’s white-label “Amazon-style” lab experience 06:30 – Three modalities: PSC, at-home kits, at-home phlebotomy 08:20 – “Where is the software actually?” Models on 3.4M lab tests 09:40 – Doctors, AI agents, and the diagnostic infrastructure layer 11:00 – Telehealth, pharma, and diagnostics as a new access door 12:40 – Business model: a new cost in a system that hates new costs Key Takeaways * Virtual care without completed labs is just Zoom. When fulfillment drops from ~70% in-clinic to ~30% in virtual, diagnosis and revenue leak out. * The real AI bottleneck is diagnostics.Agents and navigation tools only work if they can talk to lab infrastructure that actually gets tests done. * Infrastructure beats slogans.White-labeled, data-driven lab rails that convert orders to results are where virtual care and AI either succeed—or quietly fail. #boombostichealth #virtualcare #telehealth #digitalhealth #digitalhealthcare #healthcareinnovation #aiinhealthcare #patientcare #valuebasedcare #healthcare /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/39081210

Ep 50: 95% of Care From Home: The Virtual Model Changing Healthcare 11/11/2025

Ep 50: 95% of Care From Home: The Virtual Model Changing Healthcare Virtual care isn’t a feature. It’s the future care model nobody in healthcare wants to admit is already here. At HLTH 2025, we sat down with Michael Dalton, CEO and founder of Ovatient, to unpack the real story behind why rural and urban patients alike are falling through the cracks and how Ovatient built the first truly integrated virtual multi-specialty practice on Epic. This conversation exposes three uncomfortable truths in healthcare: Access is still broken. Millions delay care because transportation, work schedules, stigma, or geography get in the way. Telemedicine wasn’t enough. Single-visit, transactional virtual care doesn't build trusted relationships, close care gaps, or keep patients inside a system of care. Health systems are missing billions in preventable leakage. Ovatient’s “digital health home” model quietly fixes that. Dalton breaks down why: • A virtual-first care model that’s integrated directly into Epic makes specialists accessible within hours, not months • 95% of patients can be supported at home while still remaining inside their health system • Weight management, behavioral health, primary care, and specialty care all operate seamlessly across one unified patient journey • Virtual care isn’t cannibalizing brick-and-mortar — it’s expanding the funnel If you care about access, equity, referral management, or the economics of keeping patients connected to a system of care… this episode will challenge everything you think you know about “telemedicine.” Ovatient isn’t building a digital front door. They’re building the digital health home. And it’s changing the game. 🎧 Listen now and rethink everything you thought “virtual care” meant. Chapters 00:00 Introduction to Ovatient and Its Purpose 01:49 The Virtual Multi-Specialty Care Model 05:36 Integration with Health Systems 09:19 Building Trust in Healthcare 12:29 Closing Care Gaps with E-Consults /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/38993935

Ep 49: The Real Healthcare Disruption Isn’t AI - It’s Your DNA 11/04/2025

Ep 49: The Real Healthcare Disruption Isn’t AI - It’s Your DNA AI will accelerate healthcare — but genomics will rewrite it. The minute DNA drives care decisions for everyone, the current system becomes obsolete. Gene by Gene quietly runs one of the most advanced, high-throughput genomics labs in the world — powering platforms like MyHeritage and rapidly transforming clinical medicine, oncology, pharmacogenomics, and ancestry. This conversation explores what happens when every person leaves the hospital with a genomic passport — a lifelong DNA profile they own, control, and use to prevent disease before it begins. This is preventive medicine at scale. Not someday — now. What You’ll Learn - Why the genomics industry just flipped overnight - How AI + sequencing will routinely identify disease risk decades early - What happens when every patient controls their genomic data - How pharmacogenomics improves medication safety and outcomes - Why the healthcare system can’t keep up with genomic progress Chapters 00:00 – Live at HLTH 2025 00:29 – The quiet giant behind global genomics 01:20 – From physician to entrepreneur 02:45 – Acquiring Gene by Gene 04:19 – The massive shift to whole-genome sequencing 05:59 – Why more data = better diagnosis and prevention 07:30 – DecisionRx partnership and real-world outcomes 08:19 – Cost, speed, and modularity as the winning edge 09:52 – Sequencing every newborn at birth 11:00 – Data democratization and genomic ownership 11:59 – AI + 3 billion base pairs: why machines must lead 13:24 – Polygenic risk scoring and preventive cardiology 15:38 – Cognitive health and early-intervention models 16:40 – Nutrition + genomics: personal story 17:50 – Sleep, diet & medication metabolism 18:25 – Closing thoughts and future collaboration Learn more: #genomics #precisionmedicine #boombostichealth #DNARevolution #healthcareinnovation #futureofhealthcare #preventivemedicine #healthtech #biotechnology #artificialintelligence /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/38914590

Ep 48: Time to Treatment Accelerating the Connection to Care 10/30/2025

Ep 47: Fixing Prescription Costs with E-Prescribing and Transparency 10/29/2025

Ep 46: The Conversations You Need to Hear About AI in Healthcare 10/14/2025

Ep 45: Building an AI-Ready Future for Healthcare 10/07/2025

Ep 44: Rethinking Telemedicine - How Digital Healthcare Can Bend the $5 Trillion Cost Curve 09/30/2025

Ep 43: The $528B Fix Healthcare Can't Ignore: Why Are We Still Guessing Meds? 09/23/2025

Ep 42: MedTechs's 10X Advantage - How Real-World Data Expands Device Impact 09/16/2025

Ep 42: MedTechs's 10X Advantage - How Real-World Data Expands Device Impact Summary Pre-market clinical trials are essential — but they don’t reflect how devices truly perform once they’re in the real world. In this episode of Boombostic Health, host Bradley Bostic sits down with Dr. Amelia Hufford, Co-Founder and SVP of Clinical and Regulatory Science at 3Aware, to unpack why real-world data (RWD) is critical to the survival of medical devices — and why mindset, not science, may be the biggest barrier holding MedTech back. Amelia shares her 20+ year journey in scientific and clinical research, including a decade in MedTech leading regulatory and clinical affairs. She explains how RWD fills the gaps left by clinical trials, supports post-market surveillance, uncovers off-label use, and even opens the door to label expansion — giving manufacturers faster, less costly ways to prove safety and effectiveness. The conversation dives into the risks of ignoring RWD, the opportunities it creates for innovation and revenue, and how this shift could save one-third of devices currently at risk of disappearing from the market. What You’ll Learn in This Episode Why pre-market clinical trials don’t fully reflect everyday device usage. How real-world data provides insights into broader and more diverse patient populations. Why manufacturers fear off-label data — and how it can actually unlock new markets. The importance of treating RWD studies with the same rigor as traditional clinical research. How RWD can accelerate innovation, improve patient outcomes, reduce costs, and support regulatory compliance. Why It Matters Without embracing real-world data, the MedTech industry risks losing critical devices — some of which save lives in high-stakes scenarios. By shifting mindset and using RWD with scientific rigor, manufacturers can not only ensure patient safety but also unlock growth opportunities, accelerate label expansion, and meet regulatory demands more efficiently. Resources & Links Learn more about Connect with Follow /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/38242315

Ep 41: From 18% to 80%: The Pregnancy Risk America Ignores 09/09/2025

Ep 41: From 18% to 80%: The Pregnancy Risk America Ignores Why is giving birth in the United States still so risky—especially for Black and Native American mothers? In this powerful episode of Boombostic Health, host Bradley Bostic sits down with Tiffany Hall, a nurse and maternal health expert who has spent decades on the frontlines of patient care and blood management. Tiffany exposes the hidden pregnancy risk no one is talking about: anemia. Drawing from both clinical experience and hc1’s MyBloodHealth technology, Tiffany explains how anemia silently drives up rates of hemorrhage, heart complications, postpartum depression, and even maternal death. And while anemia is often missed in early pregnancy (18% of women in the 1st trimester), it skyrockets to 80% by the 3rd trimester—when it’s far harder to manage. The conversation also dives into the stark racial disparities in maternal outcomes: Black and Native mothers die at a rate of 49.5 per 100,000 births, compared to 19 per 100,000 for white mothers. Tiffany unpacks how fragmented care, lack of early screening, and systemic inequities continue to put mothers and babies at risk—despite being preventable. But it’s not all grim. Tiffany also shares how HerCare powered by MyBloodHealth is giving providers the tools to proactively identify risk, streamline workflows, and deliver better outcomes for both moms and babies. Guest: Tiffany Hall, Nurse and Director of cPBM Clinical Technology at hc1 What You’ll Learn in This Episode 📊 The shocking stats: anemia’s rise from 18% in the 1st trimester to 80% by the 3rd ⚠️ How anemia fuels hemorrhage, cardiovascular problems, and postpartum depression ✊ Why Black and Native mothers face mortality rates more than 2X higher than white mothers 🧪 How lab-driven insights can flip care from reactive to proactive 💡 How HerCare simplifies provider workflows and closes dangerous gaps in maternal care Why It Matters Every statistic in this episode represents mothers, babies, and families forever changed. Tiffany’s message is clear: maternal deaths and injuries in the U.S. are preventable—but only if we address hidden risks early and make proactive care the standard. Chapter Highlights: 00:00 – Intro & Guest 01:57 – Tiffany’s Background 04:46 – Mothers & Babies at Risk 05:29 – Broken U.S. Care System 08:18 – 49.5 vs 19: The Disparity 10:09 – Hidden Risk: Anemia 11:57 – How HerCare Works 19:23 – Awareness & Policy Change 22:07 – The Future of Maternal Care 27:56 – Closing & Takeaways /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/38142640

Ep 40: How AI Is Quietly Building Healthcare’s Next Multi-Billion Companies 09/02/2025

Ep 39: The Urine Test That Could Replace Invasive Cancer Biopsies 08/26/2025

Ep 38: From Lawyer to $18 5B Healthcare Deal — How Lee Shapiro Made the Leap 08/19/2025

Ep 38: From Lawyer to $18 5B Healthcare Deal — How Lee Shapiro Made the Leap What does it really take to build and scale a healthcare company? In this episode of Boombostic Health, Bradley Bostic sits down with Lee Shapiro—Managing Partner at 7wire Ventures, former President of Allscripts, and co-founder of Livongo—to talk about his journey from “recovering lawyer” to building one of the most successful companies in digital health. Lee shares how he and Glenn Tullman grew Livongo into a public company and ultimately merged with Teladoc in a landmark $18.5 billion deal. He breaks down why healthcare innovation is never an overnight success, how to spot “Uber moments” in healthtech, and why solving consumer hassles is the future of care. Whether you’re an entrepreneur, investor, or operator, this conversation offers a masterclass on building meaningful healthcare businesses that last. Key Moments 00:00 – Intro: Bradley Bostic welcomes Lee Shapiro of 7wire Ventures 01:40 – From lawyer to entrepreneur: Why Lee left law to build companies 05:20 – Allscripts and the early days of digital health 10:30 – The Livongo story: 6-year grind to IPO and $18.5B Teladoc merger 13:50 – The B2B2C model in healthcare explained 15:20 – Consumer hassle mapping: Finding healthcare’s “Uber moments” 17:20 – Value-based care & empowering the patient 19:40 – Scaling through M&A: The $620M Accolade–Transcarent deal 25:30 – How 7wire Ventures supports portfolio founders beyond capital 29:20 – Doing well by doing good: Investing with purpose in healthcare 31:10 – Cubs or Sox? Lee’s Chicago roots and final thoughts Key Topics Digital health entrepreneurship Venture capital in healthcare How Livongo scaled to an $18.5B deal with Teladoc The future of value-based care Consumer hassle mapping and patient empowerment Healthcare M&A and scaling strategies /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/37877470

Ep 37: Predicting Menopause: How Life Ahead Is Transforming Women’s Health with Science & Data 08/12/2025

Ep 37: Predicting Menopause: How Life Ahead Is Transforming Women’s Health with Science & Data Episode Description What if women could know — years in advance — when perimenopause and menopause will begin? In this episode of Boombostic Health, host Bradley Bostic talks with Nich Gentry and Dr. Lizellen La Follette of Life Ahead, a groundbreaking company combining ultrasound, personalized data, and validated science to give women a clear picture of their reproductive timeline. You’ll learn: Why ovarian aging is the “canary in the coal mine” for overall health. How early menopause prediction could transform bone health, cognitive health, and preventive care. The science behind Life Ahead’s algorithm — and why it’s a breakthrough for both patients and clinicians. Why women’s health research has been historically underfunded and how that’s changing. The entrepreneurial challenges of building a science-backed health tech company. Whether you’re in healthcare, innovation, or simply care about the future of women’s health, this conversation will leave you inspired — and rethinking what’s possible in preventive care. Listen now to learn how data, science, and proactive healthcare can rewrite the future for millions of women. Key Moments 00:00 – Why Proactive Healthcare Matters Shifting from reactive to proactive care in women’s health. 01:14 – Meet Life Ahead Nich and Dr. Lizellen share their mission to close the women’s health gap. 04:11 – Understanding Ovarian Aging Why ovaries age faster than most organs and what it means for overall health. 08:16 – Perimenopause Explained What it is, symptoms, and why timing matters. 10:11 – The Cost of Waiting How early menopause prediction could save money and improve health outcomes. 12:41 – The Science Behind the Tool From NSF funding to Yale mathematicians — the breakthrough research journey. 14:43 – The Startup Rollercoaster Highs, lows, and challenges of building a new category in healthcare. 27:17 – WHOOP, Fitness, and Sleep Why tracking recovery and lifestyle metrics is part of better healthcare. 30:17 – Looking Ahead Envisioning the future of women’s health through predictive technology. /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/37774720

Ep 36: Why Hospitals Are Selling Profitable Labs to Survive 08/05/2025

Ep 35: The 53% Failure Rate in Medicine—and How AI Can Fix It 07/29/2025

Ep 34: From Fax to Fast: The Fight for Real Healthcare Interoperability 07/22/2025

Ep 33: From Paralysis to Progress: 5 Stories Reshaping Healthcare 07/15/2025

Ep 33: From Paralysis to Progress: 5 Stories Reshaping Healthcare Episode Summary: In this special “Best Of” episode, we bring together the boldest, most unforgettable moments from our five most-watched interviews on Boombostic Health. These leaders aren’t just talking about change—they’re making it happen. In just 30 minutes, you'll hear from entrepreneurs, investors, clinicians, and health system leaders who are all challenging the business of healthcare in radically different—and deeply personal—ways. Featured Guests: Chris Leeuw – After surviving a paralyzing spinal cord injury, Chris defied the odds, relearned to walk, and launched NeuroHope to build a more humane, patient-focused model of care. Adam Heller – Venture capitalist and founder of Oakwood Circle Ventures, Adam breaks down the economic dysfunction at the heart of healthcare and why capital must follow impact, not hype. Steve Serota – As a leader in lab medicine, Steve explains why treating cancer without subspecialized pathologists is a dangerous norm—and what needs to change now. Matt Honan – A diagnostics executive who reveals how a simple lab test can prevent costly surgical complications, while saving lives and driving smarter care. David Ohm – A nonprofit health system executive showing how AI can bring operational efficiency—and better care—to underserved populations, if applied with the right intent. What You’ll Learn: Why most spinal cord injury patients are abandoned by the system—and how NeuroHope is changing that The trillion-dollar inefficiencies strangling healthcare innovation How diagnostics can shift care from reactive to proactive The hidden power of pathology—and what happens when we ignore it Why AI in healthcare isn’t just about tech—it’s about equity, governance, and trust 🎧 Listen if you’re ready to: Hear real solutions from the people building them Challenge your assumptions about healthcare innovation Get inspired by resilience, purpose, and bold leadership /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/37415885

Ep 32: Inside the Fight Against Cognitive Decline: TruNeura's Radical Approach to Brain Health 07/07/2025

Ep 32: Inside the Fight Against Cognitive Decline: TruNeura's Radical Approach to Brain Health In this episode, Bradley Bostic and James Maskell discuss the innovative approaches to addressing cognitive decline through functional and precision medicine. They explore the impact of environmental factors, particularly mold, on brain health, and the importance of a holistic approach to care. James shares his personal journey with his father's cognitive decline and how it led to the development of TruNeura, a revolutionary tool to allow any clinic to operate and scale a successful brain health protocol. The conversation highlights the need for a shift in healthcare models to better support aging populations and the potential for preventive measures in cognitive health. Watch full episode on YouTube Takeaways - Cognitive decline is a multifaceted issue influenced by environmental factors. - Mold exposure can significantly impact cognitive health. - Precision medicine offers a promising approach to reversing cognitive decline. - TruNeura aims to integrate a multimodal approach to brain health. - Holistic health programs can benefit seniors in living facilities. - The healthcare system is slowly recognizing the importance of functional medicine. - There is a growing demand for personalized cognitive health solutions. - Understanding the prodromal period is crucial for early intervention. - Community support plays a vital role in managing cognitive health. - Preventive measures can start as early as age 30. Chapters 00:00 Introduction to Cognitive Decline Solutions 02:54 Personal Journey and Mold's Impact on Cognitive Health 06:39 Understanding Environmental Determinants of Health 09:27 The Role of Precision Medicine in Cognitive Health 13:09 Developing a Software Solution for Cognitive Care 15:32 Integrating Cognitive Health in Senior Living 18:00 Holistic Health Approach to Cognitive Decline 21:00 Challenges in Implementing New Health Models 23:49 The Future of Cognitive Health and Prevention /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/37306920

Ep 31: Reversing Chronic Illness: The Future of Functional Medicine with James Maskell 06/30/2025

Ep 30: Agentic AI and Supply Chain: Redefining Efficiency in Healthcare 06/17/2025

Ep 29: The Future of Precision Medicine and Global Biobanking 06/09/2025

Ep 28: Unlocking the Secrets of Cancer: The Role of Omics 06/02/2025

Ep 28: Unlocking the Secrets of Cancer: The Role of Omics Summary In this episode of Boombostic Health, Bradley Bostic interviews Dustin Suntheimer, Director of Commercial Operations in diagnostics, to discuss the advancements in oncology testing and the impact of genetic profiling on cancer treatment. They explore the evolution of cancer diagnostics, the significance of omics, and the role of advanced genetic testing in personalizing treatment plans. The conversation also touches on the accessibility of these tests across different demographics and the future of cancer care, emphasizing the importance of collaboration between healthcare providers and laboratories. Watch full episode on YouTube Takeaways The state of oncology testing has significantly improved over the years. Advanced molecular assays can lead to better patient outcomes. Digital pathology allows for remote examination of tissue samples. Genetic testing can help eliminate ineffective treatments. Molecular profiling is essential for personalized cancer therapy. Omics encompasses various fields that enhance our understanding of biology. Precision medicine tailors treatment based on individual genetic profiles. Genetic testing should be accessible to all patients, regardless of socioeconomic status. Healthcare providers must be aware of genetic testing guidelines. Collaboration between physicians and laboratories is crucial for patient care. Chapters 00:00 Introduction to Oncology Testing and Its Evolution 03:01 Understanding Anatomic Pathology and Molecular Testing 06:00 The Importance of Genetic Profiling in Cancer Treatment 08:55 The Role of Omics in Cancer Diagnostics 11:52 Advanced Technologies in Cancer Testing 14:54 The Impact of Genetic Testing on Preventative Care 17:49 Tracking Cancer Recurrence with Advanced Testing 21:00 The Importance of Family History in Cancer Risk 24:05 Guidelines for Genetic Testing and Preventative Measures 26:55 Healthcare Innovation and the Future of Cancer Treatment 29:55 The Socioeconomic Factors in Accessing Genetic Testing 33:08 Conclusion and Future Directions in Oncology /episode/index/show/84fc912f-3f91-4b5a-a3f8-d2addda898bb/id/36819980

Ep 27: Insights with Matt Honan on Innovation, Data, and Preventative Care 05/28/2025

Boombostic Health

TOPICS